DANIEL JANNEY - 30 Jun 2025 Form 4 Insider Report for Krystal Biotech, Inc. (KRYS)

Role
Director
Signature
/s/ Krish Krishnan, as attorney-in-fact for Daniel Janney
Issuer symbol
KRYS
Transactions as of
30 Jun 2025
Net transactions value
$0
Form type
4
Filing time
30 Jun 2025, 18:14:55 UTC
Previous filing
01 Jul 2024

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
JANNEY DANIEL Director C/O KRYSTAL BIOTECH, INC., 2100 WHARTON STREET, SUITE 701, PITTSBURGH /s/ Krish Krishnan, as attorney-in-fact for Daniel Janney 30 Jun 2025 0001198325

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRYS Stock Option (Right to Buy) Award $0 +5,000 $0.000000 5,000 30 Jun 2025 Common Stock 5,000 $137.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were awarded on June 30, 2025 and vest in equal monthly tranches over a one-year period.